A Study of Enzastaurin in Patients With Leukemia

NCT00452257 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Lymphocytic

Interventions

DRUG: enzastaurin

Sponsor

Eli Lilly and Company